エーザイの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2016/12/01 | 6,668 | 6,695 | 6,530 | 6,572 | -37 | -0.6% | 1,619,400 |
| 2016/11/30 | 6,608 | 6,641 | 6,565 | 6,609 | -2 | ±0% | 1,199,400 |
| 2016/11/29 | 6,600 | 6,662 | 6,592 | 6,611 | -47 | -0.7% | 959,700 |
| 2016/11/28 | 6,650 | 6,674 | 6,581 | 6,658 | +18 | +0.3% | 980,900 |
| 2016/11/25 | 6,608 | 6,651 | 6,586 | 6,640 | +78 | +1.2% | 1,425,200 |
| 2016/11/24 | 6,700 | 6,736 | 6,555 | 6,562 | -505 | -7.1% | 3,022,500 |
| 2016/11/22 | 7,005 | 7,085 | 6,961 | 7,067 | -30 | -0.4% | 741,500 |
| 2016/11/21 | 7,012 | 7,145 | 6,992 | 7,097 | +74 | +1.1% | 741,900 |
| 2016/11/18 | 7,200 | 7,280 | 7,012 | 7,023 | -41 | -0.6% | 1,349,600 |
| 2016/11/17 | 6,960 | 7,116 | 6,940 | 7,064 | +105 | +1.5% | 952,500 |
| 2016/11/16 | 6,871 | 6,985 | 6,871 | 6,959 | +132 | +1.9% | 876,900 |
| 2016/11/15 | 6,713 | 6,830 | 6,701 | 6,827 | +97 | +1.4% | 741,200 |
| 2016/11/14 | 6,785 | 6,817 | 6,713 | 6,730 | -32 | -0.5% | 871,100 |
| 2016/11/11 | 6,830 | 6,888 | 6,733 | 6,762 | +48 | +0.7% | 1,594,400 |
| 2016/11/10 | 6,560 | 6,716 | 6,451 | 6,714 | +661 | +10.9% | 1,701,000 |
| 2016/11/09 | 6,342 | 6,470 | 5,980 | 6,053 | -324 | -5.1% | 1,957,300 |
| 2016/11/08 | 6,500 | 6,504 | 6,370 | 6,377 | -58 | -0.9% | 846,800 |
| 2016/11/07 | 6,450 | 6,486 | 6,405 | 6,435 | +61 | +1% | 1,272,500 |
| 2016/11/04 | 6,526 | 6,540 | 6,345 | 6,374 | -151 | -2.3% | 1,225,200 |
| 2016/11/02 | 6,600 | 6,624 | 6,477 | 6,525 | -109 | -1.6% | 850,100 |
| 2016/11/01 | 6,666 | 6,697 | 6,624 | 6,634 | -64 | -1% | 608,400 |
| 2016/10/31 | 6,763 | 6,845 | 6,693 | 6,698 | -119 | -1.7% | 849,600 |
| 2016/10/28 | 6,838 | 6,851 | 6,782 | 6,817 | +32 | +0.5% | 805,400 |
| 2016/10/27 | 6,785 | 6,802 | 6,731 | 6,785 | -65 | -0.9% | 560,400 |
| 2016/10/26 | 6,811 | 6,888 | 6,775 | 6,850 | +39 | +0.6% | 607,600 |
| 2016/10/25 | 6,796 | 6,837 | 6,760 | 6,811 | +6 | +0.1% | 721,000 |
| 2016/10/24 | 6,824 | 6,840 | 6,792 | 6,805 | -33 | -0.5% | 672,200 |
| 2016/10/21 | 6,890 | 6,900 | 6,817 | 6,838 | +3 | ±0% | 762,100 |
| 2016/10/20 | 6,739 | 6,839 | 6,704 | 6,835 | +161 | +2.4% | 1,124,300 |
| 2016/10/19 | 6,679 | 6,724 | 6,650 | 6,674 | +10 | +0.2% | 748,300 |
| 2016/10/18 | 6,503 | 6,675 | 6,503 | 6,664 | +104 | +1.6% | 806,000 |
| 2016/10/17 | 6,535 | 6,632 | 6,516 | 6,560 | +20 | +0.3% | 618,000 |
| 2016/10/14 | 6,622 | 6,659 | 6,534 | 6,540 | -89 | -1.3% | 1,173,900 |
| 2016/10/13 | 6,669 | 6,729 | 6,608 | 6,629 | -12 | -0.2% | 566,600 |
| 2016/10/12 | 6,558 | 6,671 | 6,544 | 6,641 | -17 | -0.3% | 832,900 |
| 2016/10/11 | 6,511 | 6,660 | 6,511 | 6,658 | +189 | +2.9% | 878,000 |
| 2016/10/07 | 6,482 | 6,514 | 6,449 | 6,469 | -7 | -0.1% | 398,900 |
| 2016/10/06 | 6,470 | 6,497 | 6,433 | 6,476 | +49 | +0.8% | 556,400 |
| 2016/10/05 | 6,463 | 6,480 | 6,385 | 6,427 | -28 | -0.4% | 532,900 |
| 2016/10/04 | 6,405 | 6,455 | 6,371 | 6,455 | +63 | +1% | 673,700 |
| 2016/10/03 | 6,333 | 6,417 | 6,310 | 6,392 | +105 | +1.7% | 503,200 |
| 2016/09/30 | 6,313 | 6,352 | 6,265 | 6,287 | -154 | -2.4% | 949,500 |
| 2016/09/29 | 6,400 | 6,469 | 6,365 | 6,441 | +73 | +1.1% | 576,900 |
| 2016/09/28 | 6,367 | 6,406 | 6,275 | 6,368 | -99 | -1.5% | 788,600 |
| 2016/09/27 | 6,379 | 6,468 | 6,288 | 6,467 | +45 | +0.7% | 1,097,600 |
| 2016/09/26 | 6,528 | 6,547 | 6,405 | 6,422 | -63 | -1% | 792,200 |
| 2016/09/23 | 6,519 | 6,537 | 6,477 | 6,485 | -41 | -0.6% | 676,000 |
| 2016/09/21 | 6,399 | 6,541 | 6,356 | 6,526 | +149 | +2.3% | 1,334,100 |
| 2016/09/20 | 6,325 | 6,391 | 6,320 | 6,377 | -47 | -0.7% | 954,900 |
| 2016/09/16 | 6,257 | 6,424 | 6,236 | 6,424 | +217 | +3.5% | 1,225,400 |
1951～
2000
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| 小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
